Onderneming BioSyent Inc. Other OTC
Aandelen
BIOYF
CA0906901081
Farmaceutische producten
Vakgebied
Verkoop per activiteit
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Pharmaceutical
96,9
%
| 27 | 96,5 % | 31 | 96,9 % | +13,61% |
Insecticide
3,1
%
| 1 | 3,5 % | 1 | 3,1 % | -0,21% |
Verkoop per regio
CAD in miljoen | 2022 | Gewicht | 2023 | Gewicht | Delta |
---|---|---|---|---|---|
Canada
95,9
%
| 27 | 96,7 % | 30 | 95,9 % | +12,16% |
Middle East
3,3
%
| 1 | 2,4 % | 1 | 3,3 % | +53,27% |
United States
0,8
%
| 0 | 0,8 % | 0 | 0,8 % | +7,49% |
Managers
Managers | Titel | Leeftijd | Van |
---|---|---|---|
René C. Goehrum
CEO | Chief Executive Officer | 64 | 01-01-96 |
Robert March
DFI | Director of Finance/CFO | - | 10-09-18 |
Navid Ashrafi
CTO | Chief Tech/Sci/R&D Officer | - | 01-05-14 |
Neelu Atwal
HRO | Human Resources Officer | - | 01-01-19 |
Corporate Officer/Principal | - | 01-08-15 | |
Kevin Wilson
PRN | Corporate Officer/Principal | - | 01-03-12 |
Besturend
Besturend | Titel | Leeftijd | Van |
---|---|---|---|
Sara Elford
BRD | Director/Board Member | 53 | 08-01-18 |
René C. Goehrum
CEO | Chief Executive Officer | 64 | 01-01-96 |
Peter Lockhard
BRD | Director/Board Member | 60 | 01-06-02 |
Larry Andrews
BRD | Director/Board Member | 71 | 08-01-18 |
Joseph Arcuri
BRD | Director/Board Member | 58 | 29-05-18 |
Stephen Wilton
BRD | Director/Board Member | 63 | 16-01-14 |
Aandelenklasse
Stemming | Aantal | Vrij verhandelbaar | Bedrijfseigen aandelen | Drijvend Totaal | |
---|---|---|---|---|---|
Aandeel A | 1 | 12 010 552 | 7 150 534 ( 59,54 %) | 213 343 ( 1,776 %) | 59,54 % |
Bedrijfsgegevens
Sector
Verkoop per activiteit
Verkoop per regio
Vaira. 1 jan. | Kapi. | |
---|---|---|
+32,09% | 694 mld. | |
+29,39% | 593 mld. | |
-1,34% | 371 mld. | |
+20,34% | 331 mld. | |
+7,39% | 290 mld. | |
+14,25% | 239 mld. | |
-3,03% | 209 mld. | |
+10,02% | 209 mld. | |
+8,49% | 169 mld. |